Sort by
Refine Your Search
-
, the system will be physicochemically and mechanically characterized, including nanoparticle properties, drug loading, release kinetics, and photothermal performance. Its therapeutic efficacy will then be
-
grant, with 1 position(s), under the project COMPETE2030-FEDER-00708800, title: High-PERformance BIOTEXtiles – Improving the stability and durability of biotextiles using natural compounds and greener
-
differentiation assays, neuroepithelial stem cell (NESC) culture, differentiation of NESCs into neural cultures, western blot, qRT-PCR, and immunocytochemistry. Handling mice and performing procedures such as tail
-
prepare scientific reports. Develop laboratory work, namely: (i) performing ecotoxicological assays with plants and (ii) evaluating physiological and toxicity parameters. V - Initial grant duration: 12
-
" setting to validate its technical performance or societal readiness. V - Initial grant duration: 6 months. V.I - Renewal Possibility: Possibily renewable VI - Funding and financial conditions of the grant
-
2030| reference of operation no. 21641, operation COMPETE2030-FEDER-02249600 on Balcão dos Fundos.[ VI.IV - Information and publicity about the funding: All R&D activities directly or indirectly financed
-
and quality applicable in the design of interactive media. The main tasks to be performed, and which will be used in the evaluation, are as follows: T1: Conduct an interdisciplinary literature review
-
) through the Programa Temático Inovação e Transição Digital (COMPETE 2030), Portugal 2030 and the European Union | Operation No. 15628, operation code in the Funds Desk COMPETE2030-FEDER-00670600. VI.V
-
- Selection Methods: Evaluation of the academic record (AR) VII.I - AR - In the evaluation of the academic record, the candidates' academic performance will be assessed according to the following weights and
-
(CENTRO 2030) of Portugal 2030; reference of operation 24502, operation code CENTRO2030-FEDER-02968200 on Balcão dos Fundos. VI.IV - Information and publicity about the funding: All R&D activities directly